⚠ COVID-19 INFORMATION: Vaccine Information, Other Resources 

Fenfluramine: New Treatment for Seizures in Dravet Syndrome

Pierce, J. G.; Mithal, D. S.

Pediatr Neurol Briefs. 2020 Mar 20; 34:8


Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.

Read More on PubMed